All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date Terminated||2008-008689-11||Efficacy and safety of omega – 3 based lipid solution (Omegaven) in comparison with Lipofundin LCT/MCT in reducing cholestasis in children on parenteral nutrition – randomized double – blind clinical ...||bad-data|
|Ongoing||2013-005528-40||Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – Tuberous Sclerosis Complex. Een lange-termijn, prospectieve studie om k...||not-yet-due|
|No trial status on register||2020-003231-19||Randomized, double-blind clinical trial of the efficacy and safety of rapamycin versus vigabatrin for the preventive treatment in infants with Tuberous Sclerosis Complex Randomizowane, podwójnie za...||bad-data|
|Ongoing||2021-000580-78||"The assessment of effectiveness and safeness of utilizing empagliflozin in the treatment of neutropenia of patients suffering from glycogenolysis type Ib" „Ocena skuteczności i bezpieczeństwa emp...||not-yet-due|
|Ongoing||2021-001375-16||DIPGEN – Multicenter, open label study using molecularly determined targeted therapies in children 3-18 years of age with DIPG (diffuse intrinsic pontine glioma- DIPG) Zastosowanie terapii celowane...||not-yet-due|
|No trial status on register||2021-004548-64||Multicenter, randomized, double-blind, placebo controlled study to assess the efficacy and safety of Rapamycin in drug Resistant Epilepsy associated with TSC (RaRE-TS) Wieloośrodkowe, randomizowan...||bad-data|
|No trial status on register||2021-006689-18||An open randomized phase II clinical trial evaluating the safety and efficacy of rapamycin in the treatment of gliomas high-grade malignant gliomas in children as part of the establishment management ...||bad-data|
|No trial status on register||2021-006702-78||Open, randomized, IInd phase clinical study evaluating the safety and efficacy of rapamycin in the treatment of drug-resistant epilepsy in children with rare and ultra-rare diseases of the central ner...||bad-data|